Chilblains accompanying interleukin-1 receptor-associated kinase (IRAK)-4 deficiency

被引：3
|
作者：
Gurung, P. [1 ]
Lee, A. S. W. [1 ]
Armon, K. [2 ]
Millington, G. W. M. [1 ]
机构：
[1] Norfolk & Norwich Univ Hosp, Dermatol Dept, Norwich, Norfolk, England
[2] Cambridge Univ Hosp, Paediat Rheumatol Dept, Cambridge, England
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2018年 / 43卷 / 05期
关键词：
D O I：
10.1111/ced.13621
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 50 条
  • [41] Recurrent infection with genetically identical pneumococcal isolates in a patient with interleukin-1 receptor-associated kinase-4 deficiency
    Szabo, Judit
    Dobay, Orsolya
    Erdos, Melinda
    Borbely, Agnes
    Rozgonyi, Ferenc
    Marodi, Laszlo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (06) : 863 - 865
  • [42] Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency:: First association with a primary immune deficiency
    Chapel, H
    Puel, A
    von Bernuth, H
    Picard, C
    Casanova, JL
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) : 1227 - 1231
  • [43] Pharmacokinetics and Pharmacodynamics of KT-474, a Novel Selective Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degrader, in Healthy Adults
    Agarwal, Sagar
    Mcdonald, Alice A.
    Campbell, Veronica
    Chen, Dapeng
    Davis, Jeff
    Rong, Haojing
    Mishkin, Aimee
    Slavin, Anthony
    Gollerkeri, Ashwin
    Gollob, Jared A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (03):
  • [44] Interleukin-1 Receptor-Associated Kinase-1 (IRAK-1) functionally associates with PKCε and VASP in the regulation of macrophage migration
    Gan, Lu
    Li, Liwu
    MOLECULAR IMMUNOLOGY, 2010, 47 (06) : 1278 - 1282
  • [45] POPULATION PHARMACOKINETICS OF GS-5718, AN ORAL INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4) INHIBITOR, IN HEALTHY SUBJECTS.
    Sathe, A.
    Anderson, K.
    McFarlane, J.
    Othman, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S45 - S45
  • [46] Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma
    Ning Li
    Jinhua Jiang
    Jing Fu
    Ting Yu
    Bibo Wang
    Wenhao Qin
    An Xu
    Mengchao Wu
    Yao Chen
    Hongyang Wang
    Journal of Experimental & Clinical Cancer Research, 35
  • [47] Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma
    Li, Ning
    Jiang, Jinhua
    Fu, Jing
    Yu, Ting
    Wang, Bibo
    Qin, Wenhao
    Xu, An
    Wu, Mengchao
    Chen, Yao
    Wang, Hongyang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [48] Configurational Differences and Binding Mechanisms of Interleukin-1 Receptor-Associated Kinase 1
    Chen, Yun-Ti
    Wu, Cheng-Hsuan
    Chen, Yi-Cyun
    Hsu, Yen-Chao
    Huang, Yu-Wei
    Yang, Jinn-Moon
    2020 IEEE 20TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOENGINEERING (BIBE 2020), 2020, : 160 - 167
  • [49] Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4
    Patra, Mahesh Chandra
    Choi, Sangdun
    MOLECULES, 2016, 21 (11)
  • [50] Interleukin-1 Receptor-Associated Kinase 4 Links Innate Immunity to the Pathogenesis of Rheumatoid Arthritis
    Joosten, Leo A. B.
    Netea, Mihai G.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (06): : 1571 - 1574
12345